Streeting invites doctors for fresh talks next week
Streeting's letter said it was "ironic" the BMA was asking for talks, pointing out he had never left the negotiating table.The talks ended last Tuesday when the union confirmed its five-day walkout was going ahead.It was the twelfth strike since spring 2023, but the first under Labour.
'Squandered goodwill'
Shortly after the election, Streeting reached a deal with resident doctors that saw a pause to industrial action.It led to a 22% increase in pay over a two-year period. They have been given another 5.4% average rise this year, but the BMA renewed strike action arguing that was not enough since pay was still a fifth lower than it was in 2008.In his letter on Wednesday, Streeting said the latest strike action was "deeply disappointing" and "entirely unnecessary" given talks that had started could have made substantive improvements to the working lives of doctors.He said the strike had had a detrimental impact on patients.And Streeting added: "Your action has also been self-defeating, because you have squandered the considerable goodwill you had with me and this government."But he said his door remained open, adding he was happy to meet early next week.It is not yet clear the scale of disruption to health services caused by the latest strike.The NHS has attempted to keep most of the non-urgent work going, such as knee and hip operations.Some hospitals reported they were able to do more than 80% of their normal activity – previously it had been as low as 50%.Resident doctors represent nearly half the medical workforce and range from doctors fresh out of university through to those with up to a decade of experience.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
16 minutes ago
- Daily Mail
DAILY MAIL COMMENT: Keir Starmer must fight for UK drug firms
The life sciences industry is among the brightest jewels in the British economy, generating £100billion a year and employing more than 300,000 people. At its heart is the development and manufacture of pharmaceuticals, notably by AstraZeneca, which spends vast sums on research and is worth £167billion. So, if this hugely successful company were to relocate to the US, it would be a disaster both for the London Stock Exchange and the wider economy. Worryingly, this is not out of the question. AstraZeneca already sells 40 per cent of its drugs to America and, following President Donald Trump 's tariff threat, is ramping up research and production there. While there are no immediate plans to desert the UK, chief executive Pascal Soriot is said to be 'flirting' with the idea. Mr Trump's latest demand that foreign drug companies cut prices to US customers or face penalties may be an added incentive. The Left has always been highly critical of 'Big Pharma', accusing it of profiteering on the backs of NHS patients. Under Jeremy Corbyn, Labour planned to create a state-owned drug manufacturer with the power to override the patents which enable firms to make profits from their research. Only last year, Sir Keir Starmer refused to help fund a new vaccine plant in Liverpool – while pouring public money into our ailing steel industry. This Government must understand that failing to nurture AstraZeneca, GSK and others would be a catastrophic mistake. And Sir Keir should realise that while they say they want to remain in the UK, they may yet change their mind. Car lenders off hook Banks and credit providers will have heaved a huge sigh of relief yesterday after the Supreme Court ruled they will not have to pay compensation to millions of motorists who bought cars on finance without being told the dealers were receiving commission on the loan. The Treasury was also delighted with the result. Had it gone the other way, damages could have been comparable to the PPI scandal, which destabilised the financial industry for more than a decade. The court decided that dealers did not have a duty to act solely for buyers and that commissions were not a form of bribery in the legal sense, as had been alleged. However, it was not a total exoneration. Court President Lord Reed also ruled that excessive commission payments were unfair and ordered one buyer who had been charged 25 per cent of the value of the car to be repaid with interest. This opens the way to further claims. Many brokers and dealers were paid behind-the-scenes commission by lenders to sign buyers up to car finance deals, a practice deemed 'unlawful' by the Court of Appeal in October last year - a decision that was successfully appealed by lenders at the Supreme Court The dealers and lenders have escaped their worst fears, but they do not come out well. They have certainly been guilty of sharp practices even if not illegal ones. The Competition and Markets Authority must now force them to clean up their act. OAPs feel the cold In September, Rachel Reeves promised she would 'put more money in pensioners' pockets'. What she didn't say is that she would take even more out. Research shows pensioner households are an average of £800 worse off after a year of Labour thanks to higher bills – mainly owing to the Chancellor's £40billion Budget tax raid. With more taxes coming down the track to fill Labour's ever-widening financial black hole, the cost of living is set to soar further. For all Ms Reeves' promises, the elderly are in for a bitter winter.
Daily Mail
44 minutes ago
- Daily Mail
Brits shouldn't be signed off work for anxiety and depression, says former Health Secretary Jeremy Hunt
Former health secretary Sir Jeremy Hunt fears society is 'over medicalising' the impact of normal traumatic events – and warned against signing people off work with anxiety and depression. The Tory grandee, who held the role between 2012 and 2018, spoke out as the Government has faced stiff opposition from its own MPs against welfare reforms. People with mental health conditions are believed to account for around half of the rise in working age adults claiming disability benefits in England and Wales since the pandemic, according to the Institute for Fiscal Studies. The number of working-age adults in England and Wales paid disability benefits rose by nearly 1million people to 2.9million between 2019 and 2024, with 7.5 per cent of 16- to 64-year-olds claiming. In a report in March, the Institute for Fiscal Studies calculated that about 500,000 of the rise is from mental health claimants. Sir Jeremy said that 'in some ways it's rather positive' that people talk openly about mental health issues. But he said: 'I do worry we are sometimes over-medicalising it. Everyone has trauma – bereavements, sometimes losing their jobs. That is not the same as mental illness. 'I think it's immoral we are signing off 3,000 people a day saying they don't have to look for work. The Tory MP, most recently Chancellor under Rishi Sunak (pictured) and who narrowly held onto his seat by 819 votes at last year's General Election, said: Everyone has trauma – bereavements, sometimes losing their jobs. That is not the same as mental illness' 'The majority of those have anxiety and depression and the one thing they need is social contact. If you sign them out of the world of work, their anxiety is going to get worse rather than better.' Sir Jeremy, speaking at the Buxton Literary Festival, Derbyshire, said the focus should be on supporting people with anxiety or depression so they can continue to work and lead their lives. The Tory MP, most recently Chancellor under Rishi Sunak and who narrowly held onto his seat by 819 votes at last year's General Election, added: 'What we should be doing is increasing mental health provision on the NHS. 'For that individual, it's far better but it's also better for Rachel Reeves when she's trying to make the numbers add up for her budget.' During the talk, Sir Jeremy backed current Tory leader Kemi Badenoch, saying his beleaguered party should not undergo another leadership change to improve its fortunes. He said: 'I don't think anyone else would have done much better. We've had four leaders in four years. If changing leader was the answer, we'd be doing much better in the polls than we are doing. 'We had the worst defeat in our history a year ago and it's going to take time for the country to give us a hearing again.' He urged Ms Badenoch to 'move on from contrition' to 'offering solutions' to Britain's problems. Sir Jeremy said: 'There's a football pitch-sized hole in politics for a party offering solutions. Labour is ducking decisions; Reform is not credible. 'I hope she [Kemi] turns things around but I recognise there's still a lot to do.' The MP, who represents Godalming and Ash, Surrey, ruled himself out of a return to frontline politics any time soon. He said: 'I made it clear to Kemi that I didn't wish to serve [in a front bench post in opposition] but if she wanted to bring me back before an election and if it would help, I would be around.' Jokingly, Sir Jeremy revealed being photographed more often with his pet labrador Poppy may have improved his poll ratings. The pet was pictured with the MP, his wife Lucia and their three children as they left 11 Downing Street for the final time following last July's election defeat. He said: 'Someone tweeted 'God, he's got a labrador, can I change the way I voted?'. That's the British public!'
Daily Mail
an hour ago
- Daily Mail
Trump demands UK pharmaceutical giants to lower drug costs sparking fears NHS could pay the price if they refuse
Donald Trump has demanded UK pharmaceutical giants lower prices for America and suggested charging others to make up the difference. He said if they didn't, the US would deploy 'every tool in our arsenal' to protect families from 'continued abusive drug prices', sparking fears the NHS will end up paying more. Mr Trump suggested he would use tariffs to push through higher prices if countries resisted. In May Mr Trump signed an executive order demanding drugmakers cut US medicine prices to match those abroad. Yesterday in a letter to 17 pharma companies he said he expected them to deliver on measures by September 29. He asked them to apply 'most favoured nation' pricing to Medicaid, the US health programme for people on low incomes. Mr Trump also asked drugmakers to offer new medicines at the same price in the US as in other developed countries. He said: 'Our citizens pay massively higher prices than other nations pay for the same exact pill... subsidizing socialism aboard [abroad].' British pharma companies AstraZeneca and GSK were among the recipients. Others included Eli Lilly, Johnson & Johnson, Pfizer and Sanofi. The UK Government said it would 'continue to work closely with the US to get the best deal for our pharma industry and deliver mutual benefits for both our countries'.
